» Articles » PMID: 37456468

Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker

Overview
Journal Cureus
Date 2023 Jul 17
PMID 37456468
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic pulmonary hemosiderosis (IPH) is a rare, potentially fatal disease characterized by recurrent diffuse alveolar hemorrhage. Presentation varies, and delay in diagnosis and treatment can result in respiratory complications and increased mortality. It is imperative to consider IPH in the differential of a patient presenting with transfusion-dependent microcytic anemia and concomitant pulmonary symptoms. This case series describes two pediatric patients with persistent severe microcytic anemia despite multiple blood transfusions. Both patients underwent extensive workup for their anemia, and ultimately, their respiratory symptoms led to their diagnosis of IPH. Both were then managed with long-term corticosteroids and had significant clinical improvement.

References
1.
Kiper N, Gocmen A, Ozcelik U, Dilber E, Anadol D . Long-term clinical course of patients with idiopathic pulmonary hemosiderosis (1979-1994): prolonged survival with low-dose corticosteroid therapy. Pediatr Pulmonol. 1999; 27(3):180-4. DOI: 10.1002/(sici)1099-0496(199903)27:3<180::aid-ppul5>3.0.co;2-8. View

2.
Ioachimescu O, Sieber S, Kotch A . Idiopathic pulmonary haemosiderosis revisited. Eur Respir J. 2004; 24(1):162-70. DOI: 10.1183/09031936.04.00116302. View

3.
Kabra S, Bhargava S, Lodha R, Satyavani A, Walia M . Idiopathic pulmonary hemosiderosis: clinical profile and follow up of 26 children. Indian Pediatr. 2007; 44(5):333-8. View

4.
Custer G, Balcerzak S, Rinehart J . Human macrophage hemoglobin-iron metabolism in vitro. Am J Hematol. 1982; 13(1):23-36. DOI: 10.1002/ajh.2830130105. View